Orca Bio
PrivateLast Round
Series F
Jan 9, 2026
Est. Valuation
$2.4B
Total Funding Raised
$775M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orca Bio is a biotechnology company that develops high-precision cell therapy products aimed at replacing diseased blood and immune systems with healthy ones.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orca Bio Comparables
Compare Orca Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sana Biotechnology | 76% | |
| Vor Biopharma | 71% | |
| Gamida Cell Ltd. | 71% |
Orca Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Jan 9, 2026 | ||||
| Series D | Jun 16, 2020 | ||||
| Series C | May 1, 2018 |
Key People
Founding team and executive leadership
Orca Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaiser Permanente Group Trust | Series D |
| DCVC Bio | Series D, VC Round |
| +ND Capital | Series D |
| Illinois Municipal Retirement Fund | Series D |
| Kaiser Foundation Hospitals | Series D |
| ND Capital | Series D |
| 8VC | Series C, Series D, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 59% MoM, reaching 17.6K.
- Jun 7, 2026
Second-generation platform, Orca-Q, is expanding its clinical footprint.
Orca Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orca Bio's valuation, stock price, and market status.
Is Orca Bio a public or private company?
Orca Bio is a private company.
What is the current stock price of Orca Bio?
Orca Bio is a private company, so its shares have no public market price. Caplight tracks Orca Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orca Bio worth (valuation)?
Orca Bio's valuation is estimated at $2.4B based on funding round data.
Can I buy Orca Bio stock?
Orca Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orca Bio's last funding round?
Orca Bio's most recent funding round was Series F on January 9, 2026.
Who are the main investors in Orca Bio?
Key investors in Orca Bio include Silicon Valley Bank, Lightspeed Venture Partners.
Will Orca Bio IPO soon?
No public IPO plans have been announced for Orca Bio.
How can I track Orca Bio secondary market activity?
Caplight tracks bids, offers, and trades in Orca Bio's shares on secondary markets.